Dilsan Pharma Impex Pvt Ltd's Insider Trades & SAST Disclosures

Visit FAQs

No reported Insider Trades available for Dilsan Pharma Impex Pvt Ltd in the Trendlyne database.

Dilsan Pharma Impex Pvt Ltd's has made SAST transactions in Rekvina Laboratories Ltd. recently where a Acquisition of 385,773 shares done . Disclosure was reported to the exchange on Feb. 21, 2025.

Add Superstar Alert
Stock Client Name Client Category Action* Reported To/By Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Period Regulation (Insider/SAST) Security Type Mode
Rekvina Laboratories
Dilsan Pharma Impex Pvt Ltd None Acquisition 20 Mar 2025 385,773 - 6.40% - 13 Jan 2025
19 Feb 2025		 SAST (29(1)) - Market
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal. 
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal. 
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
View All The Insider Trades & SAST